Elevated C-reactive protein is significantly associated with left ventricular dysfunction in patients with aortic

Hiroki Usuku1, Eiichiro Yamamoto2, Momoko Noguchi3

  • 1Department of Laboratory Medicine, Kumamoto University Hospital, Kumamoto, Japan; Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan; Center of Metabolic Regulation of Healthy Aging, Kumamoto University Faculty of Life Sciences, Kumamoto, Japan.

Insights

High C-reactive protein (CRP) levels indicate uncontrolled inflammation and are a significant risk factor for left ventricular (LV) dysfunction in patients with aortic regurgitation (AR) and collagen disease.

Area of Science:

  • Cardiology
  • Rheumatology
  • Internal Medicine

Background:

  • Collagen diseases are a significant cause of aortic regurgitation (AR).
  • Left ventricular (LV) dysfunction is a concern in AR patients, especially those with collagen disease.
  • Risk factors for LV dysfunction in AR patients with collagen disease are not well-established.

Purpose of the Study:

  • To identify risk factors for left ventricular (LV) dysfunction in patients with moderate to severe aortic regurgitation (AR) and concomitant collagen disease.
  • To investigate the association between inflammation markers and LV dysfunction in this patient cohort.

Main Methods:

  • A retrospective study of 41 patients with AR and collagen disease at Kumamoto University Hospital (January 2014 - December 2019).
  • Comparison of baseline characteristics, inflammatory markers (CRP, neutrophil-to-lymphocyte ratio), and hemoglobin levels between patients with preserved and reduced LV function.
  • Multivariable logistic regression analysis to determine independent predictors of LV dysfunction.

Main Results:

  • Patients with reduced LV function had significantly higher B-type natriuretic peptide, C-reactive protein (CRP), and neutrophil-to-lymphocyte ratio, and lower hemoglobin levels compared to those with preserved LV function.
  • No significant differences were observed in collagen disease type or AR severity between the groups.
  • High CRP levels (≥1.0 mg/dl) were independently and significantly associated with LV dysfunction (odds ratio: 95.7, p < 0.01).

Conclusions:

  • Uncontrolled inflammation, indicated by elevated CRP levels, is a crucial marker for LV dysfunction in patients with AR and collagen disease.
  • CRP levels serve as an important predictor of LV dysfunction in this specific patient population.
  • Managing inflammation may be key in preventing or mitigating LV dysfunction in AR patients with collagen disease.
Abstract

Related Concept Videos

Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
208
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
199
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
209
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
178
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
231
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
355